Elixinol Global buys Germany’s CannaCare in cash-and-stock deal



CBD maker Elixinol World-wide has acquired German CBD brand name CannaCare Health and fitness GmbH as it executes its strategy to pursue industry prospects in Europe.

Elixinol reported it is buying the organization for 3 million euros in dollars ($3.6 million) furthermore 6 million euros in Elixinol shares ($7.2 million). The offer calls for Elixinol to pay out up to 24 million euros ($29 million) if sure sales objectives are achieved.

CannaCare is based mostly in Hamburg, Germany, and tends to make CBD oils, sprays and skincare products. The products are offered in 4,500 brick-and-mortar retail distribution points in Germany.

Elixinol CEO Oliver Horn reported past summertime that the international CBD company would focus on European CBD markets mainly because the U.S. CBD sector is “just so cluttered.”

Elixinol maintains headquarters in both Westminster, Colorado, and Sydney, Australia. Elixinol Worldwide trades on the Australian Stock Trade as EXL and on U.S. about-the counter-markets as ELLXF.